Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC (Coimbra)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2007 by Grupo Portugues de Estudo do Cancro do Pulmao.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Grupo Portugues de Estudo do Cancro do Pulmao
ClinicalTrials.gov Identifier:
NCT00561054
First received: November 19, 2007
Last updated: NA
Last verified: November 2007
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given